Our recognition
Hikma named second-largest manufacturing employer in central Ohio, US
European Mediscience Awards 2025
Hikma wins Best Communication Award
2024 Governor’s Environmental Excellence Award Winners, New Jersey
Sustainability excellence award for onsite improvements at our Cherry Hill facility, in line with our commitment to greener operations and enhanced environmental performance.
Vizient, Inc Awards
Won 2024 Pharmaceutical Supply Assurance Supplier of the Year.
Jordan Social Security Corporation
Won best Facility in the Pharmaceuticals Sector in Health and Safety 2024
IR Society Awards 2023
Won best IR Programme award. November 2023
Certificate of Appreciation
Received a certificate of appreciation by the Sixth of October City Authorities in cooperation with the Egyptian Environmental Affairs Agency for our efforts in preserving the environment
GOLD status
Received GOLD status by the Ohio Environmental Protection Agency’s Encouraging Environmental Excellence (E3) 2022
LEED “Gold”
Received Leadership for Energy and Environmental Design (LEED) “Gold” rating for our MENA HQ building in Jordan
European Mediscience Awards
Won Best Communication Award 2022
Late founder Samih Darwazah honored with prestigious recognition from HM King Abdullah II
Jordan's First State Centennial Awards May 2021
Latest stories
Hikma delivers strong 2023 performance and a positive outlook for 2024
- Hikma announces CEO change and Board appointment Press Release, Corporate 15 December 2025 Hikma announces CEO change and Board appointment
- Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy Story, Leadership 15 December 2025 Inspiring women of Hikma - Meet Cristina Cagnazzi, Finance Director, Hikma Italy
- European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada Insight, Corporate 08 December 2025 European Injectables growth: a Q&A with Nassim Rahmani, Associate VP, Commercial Europe & Canada
- Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US Press Release, Product 08 December 2025 Hikma launches TYZAVAN™ (vancomycin injection, USP) in the US